RETRACTED: 1,25‐Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2‐antioxidant signaling and inactivation of p16/p53‐senescence signaling
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Post-publication record
- Nature
- Retraction
- Reason
- Duplication of/in Image;Error in Image;Manipulation of Images;Objections by Author(s);Unreliable Data;
- Date
- 10/18/2024 0:00
- Flagged by OpenAlex?
- Yes
Source: Retraction Watch, joined by DOI. OpenAlex records retraction as is_retracted, a boolean over a state space with at least four values, so it cannot express an expression of concern, a correction or a reinstatement — it reports them as false, which reads as “fine”.
Abstract
Abstract We tested the hypothesis that 1,25‐dihydroxyvitamin D 3 [1α,25(OH) 2 D 3 ] has antiaging effects via upregulating nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2), reducing reactive oxygen species (ROS), decreasing DNA damage, reducing p16/Rb and p53/p21 signaling, increasing cell proliferation, and reducing cellular senescence and the senescence‐associated secretory phenotype (SASP). We demonstrated that 1,25(OH) 2 D 3 ‐deficient [1α(OH)ase −/− ] mice survived on average for only 3 months. Increased tissue oxidative stress and DNA damage, downregulated Bmi1 and upregulated p16, p53 and p21 expression levels, reduced cell proliferation, and induced cell senescence and the senescence‐associated secretory phenotype (SASP) were observed. Supplementation of 1α(OH)ase −/− mice with dietary calcium and phosphate, which normalized serum calcium and phosphorus, prolonged their average lifespan to more than 8 months with reduced oxidative stress and cellular senescence and SASP. However, supplementation with exogenous 1,25(OH) 2 D 3 or with combined calcium/phosphate and the antioxidant N ‐acetyl‐ l ‐cysteine prolonged their average lifespan to more than 16 months and nearly 14 months, respectively, largely rescuing the aging phenotypes. We demonstrated that 1,25(OH) 2 D 3 exerted an antioxidant role by transcriptional regulation of Nrf2 via the vitamin D receptor (VDR). Homozygous ablation of p16 or heterozygous ablation of p53 prolonged the average lifespan of 1α(OH)ase −/− mice on the normal diet from 3 to 6 months by enhancing cell proliferative ability and reducing cell senescence or apoptosis. This study suggests that 1,25(OH) 2 D 3 plays a role in delaying aging by upregulating Nrf2, inhibiting oxidative stress and DNA damage，inactivating p53‐p21 and p16‐Rb signaling pathways, and inhibiting cell senescence and SASP.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Aging Cell
- Topic
- Vitamin D Research Studies
- Field
- Medicine
- Canadian institutions
- McGill University Health Centre
- Funders
- National Key Research and Development Program of ChinaResearch Committee, Aristotle University of ThessalonikiCanadian Institutes of Health ResearchNational Natural Science Foundation of China
- Keywords
- SenescenceOxidative stressBiologyReactive oxygen speciesDNA damageApoptosisCalcitriol receptorDownregulation and upregulationAntioxidantCell growthCell biologyEndocrinologyInternal medicineVitamin D and neurologyBiochemistryDNAGeneMedicine
- Has abstract in OpenAlex
- yes